Description

Product Description

Vastarel MR 35 mg Tablets contains Trimetazidine Modified Release, used to improve cardiac energy metabolism and help reduce symptoms of stable angina by enhancing oxygen utilization in heart cells.

Active Ingredient

Trimetazidine Dihydrochloride MR 35 mg.

Indications

Stable angina pectorisCardiac energy metabolism support

Reduction of ischemic symptoms

Support during physical exertion in cardiac patients

Warnings

Use under medical supervisionMay rarely cause dizziness or movement disorders

Inform doctor if neurological symptoms occur

Regular medical follow-up is required

Storage

Store in a cool dry placeProtect from heat, moisture, and direct sunlight